Acta Neuropathologica Communications

Article	Citations
Novel histotypes of sporadic Creutzfeldt–Jakob disease linked to 129MV genotype	380
Axonal autophagic vesicle transport in the rat optic nerve in vivo under normal conditions and during acute axonal degeneration	197
Fast and slow strains of misfolded mutant superoxide dismutase 1 in familial amyotrophic lateral sclerosis	125
Correction to: Integrated genomic analysis reveals actionable targets in pediatric spinal cord low-grade gliomas	85
Correction: Investigating genotype-phenotype correlation of limb-girdle muscular dystrophy R8: association of clinical severity, protein biological function and protein oligomerization	77
Histomorphological variations in progressive multifocal leukoencephalopathy correlated with JCV replication in brain lesions: insights from 91 patients	75
Early biomarkers in the presymptomatic phase of cognitive impairment: changes in the endocannabinoidome and serotonergic pathways in Alzheimer's-prone mice after mTBI	67
Correction to: Alzheimer’s disease tau is a prominent pathology in LRRK2 Parkinson’s disease	66
Single cell protein profiling of focal cortical dysplasia in a patient requiring multiple resections	65
DNA methylation as a contributor to dysregulation of STX6 and other frontotemporal Lobar degeneration genetic risk-associated loci	63
CUX1::MET fusion defines an indolent subtype of diffuse low-grade glioma, MAPK pathway–altered	62
Alpha-synuclein seeding activity in postmortem tissues from patients with diffuse and isolated Lewy bodies	59
Prognostic relevance of MIB-1 labeling index in VHL-associated and sporadic spinal hemangioblastomas: a subgroup analysis from a multicentric study	58
SARS-Cov-2 infection and neuropathological findings: a report of 18 cases and review of the literature	56
Low-intensity open-field blast exposure effects on neurovascular unit ultrastructure in mice	56
Spatiotemporal perturbations of the plasminogen activation system in a rat model of acute organophosphate intoxication	56
Early axonal injury in fentanyl intoxication	55
α-Synuclein overexpression increases the tropism of pre-formed fibrils and MSA-patient derived seeds towards oligodendroglia	54
Detection of structural DNA variants in medulloblastomas using optical genome mapping	54
High-plex spatial protein profiling of skeletal muscle biopsies in inflammatory myopathies using the MACSima™ imaging platform: A pilot study	53
Efficacy of BRAF/MEK-inhibitor therapy for epithelioid glioblastoma with a novel BRAFV600 mutation	52
Neutrophil infiltration and microglial shifts in sepsis induced preterm brain injury: pathological insights	52
Machine learning quantification of Amyloid-β deposits in the temporal lobe of 131 brain bank cases	52
Amyloid quantification in the oldest-old: selecting regions for optimizing correspondence between postmortem pathology and amyloid PET	51
Clarification of the published survival analysis in H3F3B p.K27I-mutant diffuse midline glioma	49

Single-cell spatial proteomic imaging for human neuropathology	49
MGMT methylation pattern of long-term and short-term survivors of glioblastoma reveals CpGs of the enhancer region to be of high prognostic value	49
Bruton’s tyrosine kinase inhibition reduces disease severity in a model of secondary progressive autoimmune demyelination	48
High-grade astrocytoma with piloid features: a single-institution case series and literature review	48
NAD salvage pathway machinery expression in normal and glaucomatous retina and optic nerve	48
A toxic gain-of-function mechanism in C9orf72 ALS impairs the autophagy-lysosome pathway in neurons	47
Tau seeding in cases of multiple sclerosis	47
The genomic alterations in glioblastoma influence the levels of CSF metabolites	44
Regulating microglial miR-155 transcriptional phenotype alleviates Alzheimer’s-induced retinal vasculopathy by limiting Clec7a/Galectin-3+ neurodegenerative microglia	43
Clinicopathologic features of two unrelated autopsied patients with Charcot-Marie-Tooth disease carrying MFN2 gene mutation	42
Dose-dependent CHCHD10 dysregulation dictates motor neuron disease severity and alters creatine metabolism	42
NRF2/ARE mediated antioxidant response to glaucoma: role of glia and retinal ganglion cells	42
Molecular pathology, developmental changes and synaptic dysfunction in (pre-) symptomatic human C9ORF72-ALS/FTD cerebral organoids	41
Exogenous interleukin 33 enhances the brain’s lymphatic drainage and toxic protein clearance in acute traumatic brain injury mice	41
Unsupervised machine learning identifies distinct ALS molecular subtypes in post-mortem motor cortex and blood expression data	41
Clinical and functional characterization of a long survivor congenital titinopathy patient with a novel metatranscript-only titin variant	40
4R-tau isoform induction via TDP-43 in neurons in response to insulin: converging signaling pathways with implications for neurodegenerative disease	40
Diffuse glioneuronal tumor with oligodendroglioma-like features and nuclear clusters (DGONC), new name and new problems: an illustration of one case with atypical morphology and biology	40
Siponimod inhibits disease-associated microglia-T cell interactions in chronic experimental autoimmune encephalomyelitis	40
TrkA activation sustains chemotherapy resistance in chemotolerant medulloblastoma cells	39
A microdeletion event at 19q13.43 in IDH-mutant astrocytomas is strongly correlated with MYC overexpression	39
Cerebellar granule neurons induce Cyclin D1 before the onset of motor symptoms in Huntington’s disease mice	39
Age-dependent interactions of APOE isoform 4 and Alzheimer’s disease neuropathology: findings from the NACC	38
Torpor induces reversible tau hyperphosphorylation and accumulation in mice expressing human tau	38
A sellar presentation of a WNT-activated embryonal tumor: further evidence of an ectopic medulloblastoma	38
CX3CL1/CX3CR1 axis dysregulation contributes to epileptogenic mechanisms in focal cortical dysplasia	36
Clinical and inflammatory factors associated with the extent of resection in primary, sporadic vestibular schwannomas: A retrospective study	36
The tumour immune microenvironment is enriched but suppressed in vestibular schwannoma compared to meningioma: therapeutic implications for NF2-related schwannomatosis	35
Differential vulnerability of the dentate gyrus to tauopathies in dementias	35
Therapeutic potential of NGF-enriched extracellular vesicles in modulating neuroinflammation and enhancing peripheral nerve remyelination	34
WFS1 gene delivery rescues visual function in a mouse model of Wolfram syndrome	34
VAPB confers selective neuroprotection by driving autophagic degradation of pathogenic aggregates in ALS	34
Advancing prion diagnostics: full-length human E200K RT-QuIC substrate facilitates prion detection in tear fluid and improves sensitivity in cerebrospinal fluid	33
ROS-regulated SUR1-TRPM4 drives persistent activation of NLRP3 inflammasome in microglia after whole-brain radiation	33
EMP3 sustains oncogenic EGFR/CDK2 signaling by restricting receptor degradation in glioblastoma	33
VGLL-fused intraparenchymal schwannoma with EWSR1::VGLL1 fusion: integrated clinicopathological and molecular characterization	33
Therapeutic potential of targeting Nrf2 by panobinostat in pituitary neuroendocrine tumors	32
ER stress induced immunopathology involving complement in CADASIL: implications for therapeutics	32
Kinetic parameters of alpha-synuclein seed amplification assay correlate with cognitive impairment in patients with Lewy body disorders	32
Ex vivo expanded human regulatory T cells modify neuroinflammation in a preclinical model of Alzheimer’s disease	32
Correction: Neuroinflammation is associated with Alzheimer’s disease co-pathology in dementia with Lewy bodies	31
Mitochondrial dysfunction is a key pathological driver of early stage Parkinson’s	31
Facilitated α-synuclein oligomer sharing among glial cells by a centrally acting connexin inhibitor attenuates a rapidly progressive multiple system atrophy-cerebellar type model by reducing the neuro	30
Accurate detection of pathologic α-synuclein in CSF, skin, olfactory mucosa, and urine with a uniform seeding amplification assay	30
Co-deposition of SOD1, TDP-43 and p62 proteinopathies in ALS: evidence for multifaceted pathways underlying neurodegeneration	29
Molecular and spatial heterogeneity of microglia in Rasmussen encephalitis	29
Dissecting acute neuronal responses to glioblastoma using a dual-interface human iPSC neuronal culture platform	29
Molecular and clinicopathologic characteristics of CNS embryonal tumors with BRD4::LEUTX fusion	29
Decreased PP2A expression and activity represent a therapeutic target for plexiform neurofibroma	29
Single-cell transcriptome sequencing reveals new epithelial-stromal associated mesenchymal-like subsets in recurrent gliomas	29

MANF protein expression is upregulated in immune cells in the ischemic human brain and systemic recombinant MANF delivery in rat ischemic stroke model demonstrates anti-inflammatory effects	28
Decoding key cell sub-populations and molecular alterations in glioblastoma at recurrence by single-cell analysis	28
Hydrogen peroxide induced by nerve injury promotes axon regeneration via connective tissue growth factor	28
Patients with sporadic FTLD exhibit similar increases in lysosomal proteins and storage material as patients with FTD due to GRN mutations	28
Blood biomarker fingerprints in a cohort of patients with CHRNE-related congenital myasthenic syndrome	27
A novel ELOVL4 variant, L168S, causes early childhood-onset Spinocerebellar ataxia-34 and retinal dysfunction: a case report	27
DNA methylation profiling from cerebrospinal fluid as a diagnostic tool for pineoblastoma	27
The role of neuromuscular ultrasound in diagnostics of peripheral neuropathies induced by cytostatic agents or immunotherapies	27
Regional vulnerability of brain white matter in vanishing white matter	27
Viral-mediated knockdown of Atxn2 attenuates TDP-43 pathology and muscle dysfunction in the PFN1C71G ALS mouse model	27
Age-dependent vascular and neurological characteristics of CADASIL are recapitulated in Notch3 mutant zebrafish, implicating a role for type IV collagen in disease progression	26
Diagnostic accuracy of a minimal immunohistochemical panel in at/rt molecular subtyping, correlated to dna-methylation profiling	26
Identification and validation of a tear fluid-derived protein biomarker signature in patients with amyotrophic lateral sclerosis	26
Immune stimulation recruits a subset of pro-regenerative macrophages to the retina that promotes axonal regrowth of injured neurons	26
Correction to: Interplay between androgen and CXCR4 chemokine signaling in myelin repair	26
Enhancing mitosis quantification and detection in meningiomas with computational digital pathology	26
Establishment of a patient-derived 3D in vitro meningioma model in xeno-free hydrogel for clinical applications	26
Bradykinesia and postural instability in a model of prodromal synucleinopathy with α-synuclein aggregation initiated in the gigantocellular nuclei	26
Oral nicotinamide provides robust, dose-dependent structural and metabolic neuroprotection of retinal ganglion cells in experimental glaucoma	25
Alpha-synuclein-induced stress sensitivity renders the Parkinson’s disease brain susceptible to neurodegeneration	25
Meningeal-tumor interactions define distinct modes of leptomeningeal colonization in Group 3 medulloblastoma	25
Myelin in Alzheimer’s disease: culprit or bystander?	24
Dysregulation of complement at the synapse in P301S mice and human tauopathies	24
Targeting RACK1 to alleviate TDP-43 and FUS proteinopathy-mediated suppression of protein translation and neurodegeneration	24
Dynamic integration of skeletal muscle signals via extracellular vesicles in motor neuron diseases	24
The G51D SNCA mutation generates a slowly progressive α-synuclein strain in early-onset Parkinson’s disease	24
Retinal ganglion cell vulnerability to pathogenic tau in Alzheimer’s disease	24
Concurrent ependymal and ganglionic differentiation in a subset of supratentorial neuroepithelial tumors with EWSR1-PLAGL1 rearrangement	24
A case of primary optic pathway demyelination caused by oncocytic oligodendrogliopathy of unknown origin	23
Systemic IGF-1 administration prevents traumatic brain injury induced gut permeability, dysmorphia, dysbiosis, and the increased number of immature dentate granule cells	23
Oedematic-atrophic astrocytes in hepatic encephalopathy	23
The ATXN2 9 bp duplication in SCA3: clarifying evidence and correcting misinterpretations	22
Integrated analysis of molecular and clinical features associated with overall survival in melanoma patients with brain metastasis	22
Astrocytes carrying LRRK2 G2019S exhibit increased levels of clusterin chaperone via miR-22-5p and reduced ability to take up α-synuclein fibrils	22
MGMT promoter methylation modulates the effect of residual tumor on survival after re-resection of recurrent glioblastoma	22
Correction: Small molecule treatment alleviates photoreceptor cilia defects in LCA5-deficient human retinal organoids	22
Toward a generalizable machine learning workflow for neurodegenerative disease staging with focus on neurofibrillary tangles	22
Evaluation of Rho kinase inhibitor effects on neuroprotection and neuroinflammation in an ex-vivo retinal explant model	22
Gene-expression profiling of individuals resilient to Alzheimer's disease reveals higher expression of genes related to metallothionein and mitochondrial processes and no changes in the unfolded prote	22
Stem cell phenotype predicts therapeutic response in glioblastomas with MGMT promoter methylation	22
APOE-ε4 and BIN1 increase risk of Alzheimer’s disease pathology but not specifically of Lewy body pathology	22
Shaping the future of preclinical development of successful disease-modifying drugs against Alzheimer's disease: a systematic review of tau propagation models	22
Unveiling the intricate dynamics of the interplay between triple-negative breast cancer cells and the blood-brain barrier endothelium	21
Acquisition of neurodegenerative features in isogenic OPTN(E50K) human stem cell-derived retinal ganglion cells associated with autophagy disruption and mTORC1 signaling reduction	21
Structural and functional studies of the VAPB-PTPIP51 ER-mitochondria tethering proteins in neurodegenerative diseases	21
Development, validation, and utility of a clinically applicable methylation classifier for recurrence risk prediction in meningiomas	21
LXR agonist rescues synaptic dysfunction and degeneration in SPG3A patient-specific iPSC-derived neurons	21
ALS-linked mutant TDP-43 in oligodendrocytes induces oligodendrocyte damage and exacerbates motor dysfunction in mice	21
Mass cytometric analysis of the immune cell landscape after traumatic brain injury elucidates the role of complement and complement receptors in neurologic outcomes	21
Proximity proteomics reveals unique and shared pathological features between multiple system atrophy and Parkinson’s disease	21
Chronic cerebral hypoperfusion: a critical feature in unravelling the etiology of vascular cognitive impairment	21
Towards a single-assay approach: a combined DNA/RNA sequencing panel eliminates diagnostic redundancy and detects clinically-relevant fusions in neuropathology	21
Neuro-glial lipid imbalance in a Drosophila model of amyotrophic lateral sclerosis 8	21
Cathepsin B abundance, activity and microglial localisation in Alzheimer’s disease-Down syndrome and early onset Alzheimer’s disease; the role of elevated cystatin B	21
LCN2/SLC22A17 mediates the phagocytosis of GABAergic synapses by oligodendrocyte progenitor cells and contributes to cancer-induced pain and comorbid anxiety-like behaviors in mice	20
Phenotypically concordant distribution of pick bodies in aphasic versus behavioral dementias	20
Activated alpha 9 integrin expression enables sensory pathway reconstruction after spinal cord injury	20
Movement disorders are linked to TDP-43 burden in the substantia nigra of FTLD-TDP brain donors	20
Repeat length of C9orf72-associated glycine–alanine polypeptides affects their toxicity	20
Integrated molecular and detailed anatomical profiling identifies a prognostically adverse subtype of posterior fossa meningiomas: high-risk copy number alterations are associated with midline predile	20
Upregulation of carbonic anhydrase 1 beneficial for depressive disorder	19
Antagonizing Il10 and Il4 signaling via intracerebral decoy receptor expression attenuates Aβ accumulation	19
Epitranscriptomic analysis reveals clinical and molecular signatures in glioblastoma	19
Correction: High-resolution transcriptomics informs glial pathology in human temporal lobe epilepsy	19
Tumor-like proliferation of CCM3 knockout endothelial cells: insights from semaxinib treatment and transcriptome profiling of co-cultures	19
Retraction Note: Anti-α-synuclein immunotherapy reduces α-synuclein propagation in the axon and degeneration in a combined viral vector and transgenic model of synucleinopathy	19
Bridging the gap: investigating the role of phosphorylation at the serine 129 site of α-synuclein in VAPB-PTPIP51 interactions	19
Intracranial mesenchymal tumor with (novel) COX14::PTEN rearrangement	19
Higher disease reactivation risk in women after fingolimod withdrawal	19
PIT-1/SF-1-positive pituitary tumors in patients with acromegaly: transcriptomic perspective	19
H3F3B p.K27I-mutant diffuse midline glioma is a distinct subtype of H3K27-altered diffuse midline glioma	19
NTRK-fused central nervous system tumours: clinicopathological and genetic insights and response to TRK inhibitors	18
Host genetics and gut microbiota influence lipid metabolism and inflammation: potential implications for ALS pathophysiology in SOD1G93A mice	18
MAPT haplotype-associated transcriptomic changes in progressive supranuclear palsy	18
Stimulating VAPB-PTPIP51 ER-mitochondria tethering corrects FTD/ALS mutant TDP43 linked Ca2+ and synaptic defects	18
Genome-wide CRISPR-Cas9 knockout screens identify DNMT1 as a druggable dependency in sonic hedgehog medulloblastoma	18
Blocking peptidyl arginine deiminase 4 confers neuroprotective effect in the post-ischemic brain through both NETosis-dependent and -independent mechanisms	18
TDP-43 pathology is associated with divergent protein profiles in ALS brain and spinal cord	18
Time-dependent prognostic value of automated Ki67 assessment and its integration with molecular risk profiling in WHO grade 2 meningioma	18
Inflammation alters myeloid cell and oligodendroglial iron-handling in multiple sclerosis	18

Accumulation of membrane repair-associated proteins and mature myostatin are novel markers of muscle pathophysiology in Pompe disease	18
Small molecule treatment alleviates photoreceptor cilia defects in LCA5-deficient human retinal organoids	18
Tau seeding activity in various regions of down syndrome brain assessed by two novel assays	18
Correction: Tau seed amplification assay reveals relationship between seeding and pathological forms of tau in Alzheimer’s disease brain	17
Spatio-temporal dynamics of microglia phenotype in human and murine cSVD: impact of acute and chronic hypertensive states	17
Investigating genotype-phenotype correlation of limb-girdle muscular dystrophy R8: association of clinical severity, protein biological function and protein oligomerization	17
Single-nucleus multi-omics of Parkinson’s disease reveals a glutamatergic neuronal subtype susceptible to gene dysregulation via alteration of transcriptional networks	17
DNA methylation, combined with RNA sequencing, provide novel insight into molecular classification of chordomas and their microenvironment	17
Usefulness OF SOX10 immunohistochemistry for subtyping diffuse midline gliomas EGFR-altered	17
TDP43 pathology in chronic traumatic encephalopathy retinas	17
Synergistic antitumor effect of temozolomide and perampanel in pediatric glioma: a case report and in vitro validation using patient-derived glioma sphere cells	17
Curative timed NK cell-based immunochemotherapy aborts brain tumour recurrence driven by mesenchymal glioma stem cells	17
Current molecular understanding of central nervous system schwannomas	17
ApoER2-Dab1 disruption as the origin of pTau-associated neurodegeneration in sporadic Alzheimer’s disease	17
miRNA-211 maintains metabolic homeostasis in medulloblastoma through its target gene long-chain acyl-CoA synthetase 4	17
Pediatric high-grade gliomas with concomitant RB1 and SETD2 alterations and Li-Fraumeni syndrome	17
Targeting NAD + biosynthesis suppresses TGF-β1/Smads/RAB26 axis and potentiates cisplatin cytotoxicity in non-small cell lung cancer brain metastasis	17
Imaging features and consideration of progression pattern of diffuse hemispheric gliomas, H3 G34-mutant	17
Molecular characteristics of isocitrate dehydrogenase 1 R132C–mutant diffuse gliomas: association with TP53 alterations and Li-Fraumeni syndrome	17
Higher angiotensin-converting enzyme 2 (ACE2) levels in the brain of individuals with Alzheimer’s disease	17
Current states in understanding oligodendroglia-mediated neurological issues in neurofibromatosis type 1 (NF1)	17
Operationalizing postmortem pathology-MRI association studies in Alzheimer’s disease and related disorders with MRI-guided histology sampling	16
Progesterone receptor distribution in the human hypothalamus and its association with suicide	16
Disseminated diffuse midline gliomas, H3K27-altered mimicking diffuse leptomeningeal glioneuronal tumors: a diagnostical challenge!	16
Distinct forebrain regions define a dichotomous astrocytic profile in multiple system atrophy	16
A patient-derived cell model for malignant transformation in IDH-mutant glioma	16
Inhibition of acid sphingomyelinase reduces reactive astrocyte secretion of mitotoxic extracellular vesicles and improves Alzheimer’s disease pathology in the 5xFAD mouse	16
Timing of microglial ablation determines protection from tau-mediated neurodegeneration and cognitive decline	16
Copper supplementation mitigates Parkinson-like wild-type SOD1 pathology and nigrostriatal degeneration in a novel mouse model	16
BCKDK loss impairs mitochondrial Complex I activity and drives alpha-synuclein aggregation in models of Parkinson’s disease	16
Cortical microvascular raspberries and ageing: an independent but not exclusive relationship	16
Expanding clinicopathologic knowledge in high-grade glioma with pleomorphic and pseudopapillary features (HPAP): a report of two cases	16
DNA hypomethylator phenotype reprograms glutamatergic network in receptor tyrosine kinase gene-mutated glioblastoma	15
The mGluR5 agonist CHPG enhances human oligodendrocyte differentiation	15
Pathological changes induced by Alzheimer’s brain inoculation in amyloid-beta plaque-bearing mice	15
Muscle transcriptome profiling reveals novel molecular pathways and biomarkers in laminin-α2 deficient patients	15
Trem2-deficiency aggravates and accelerates age-related myelin degeneration	15
Disordered DNA methylation leads to targetable transcriptional plasticity in ATRT	15
Cognitively impaired aged Octodon degus recapitulate major neuropathological features of sporadic Alzheimer’s disease	15
Immunological and tumor-intrinsic mechanisms mediate the synergistic growth suppression of experimental glioblastoma by radiotherapy and MET inhibition	15
TDP-43 overexpression in the hypothalamus drives neuropathology, dysregulates metabolism and impairs behavior in mice	15
Tau seed amplification assay reveals relationship between seeding and pathological forms of tau in Alzheimer’s disease brain	15
Rab7a is required to degrade select blood-brain barrier junctional proteins after ischemic stroke	15
Context of use matters: interpreting extracellular vesicle TDP-43 as a biomarker in ALS	15
The contribution of DNA methylation to the (dys)function of oligodendroglia in neurodegeneration	15
Methamphetamine hijacks chaperone-mediated autophagy to degrade GPX4, driving ferroptosis-precipitated cognitive decline and addictive pathogenesis	15
Cryo-EM studies of amyloid-β fibrils from human and murine brains carrying the Uppsala APP mutation (Δ690–695)	15
Dissection of transcriptomic and epigenetic heterogeneity of grade 4 gliomas: implications for prognosis	15
TDP-43 pathology is sufficient to drive axon initial segment plasticity and hyperexcitability of spinal motoneurones in vivo in the TDP43-ΔNLS model of Amyotrophic Lateral Sclerosis	15
Quantitative multiplex immunohistochemistry with colorimetric staining (QUIVER) may still benefit from MILAN	14
Low-input CSF cfDNA shallow whole-genome sequencing for CNV-based diagnosis and monitoring of leptomeningeal metastasis in lung cancer	14
Development and characterization of novel anti-acetylated tau monoclonal antibodies to probe pathogenic tau species in Alzheimer’s disease	14
Brain and circulating EV proteome signatures in schizophrenia as prognostic markers for age-related dementia	14
Clinicopathologic, molecular and tumor immune microenvironment features of mismatch repair-deficient glioblastomas in Lynch syndrome: a multicenter study of 29 cases with therapeutic implications	14
Altered amyloid-β structure markedly reduces gliosis in the brain of mice harboring the Uppsala APP deletion	14
Rapid intraoperative boundary diagnosis of somatotroph pituitary neuroendocrine tumors using real-time PCR	14
Transcription factor-based classification of pituitary adenomas / PitNETs: a comparative analysis and clinical implications across WHO 2004, 2017 and 2022 in 921 cases	14
Spatially resolved transcriptomics reveals genes associated with the vulnerability of middle temporal gyrus in Alzheimer’s disease	14
Different MAPT haplotypes influence expression of total MAPT in postmortem brain tissue	14
RNF168 dephosphorylation ameliorates cognitive decline in Aβ-based mouse models of Alzheimer’s disease	14
Neurofibromatosis type 1-dependent alterations in mouse microglia function are not cell-intrinsic	14
Acquired neuropathology and its associations with key patterns of placental pathology	14
Regional wasteosome accumulation across neurodegenerative diseases points to a shared underlying mechanism potentially related to glymphatic insufficiency	14
The neuropathological landscape of small vessel disease and Lewy pathology in a cohort of Hispanic and non-Hispanic White decedents with Alzheimer disease	14
Publisher Correction: Exploring the significance of caspase-cleaved tau in tauopathies and as a complementary pathology to phospho-tau in Alzheimer’s disease: implications for biomarker development an	14
Plasma proteome profiling identifies changes associated to AD but not to FTD	14
Lack of junctional adhesion molecule (JAM)-B traps CD8 T cells in CNS border zones and ameliorates autoimmune neuroinflammation	14
Homozygous CDKN2A/B deletions in low- and high-grade glioma: a meta-analysis of individual patient data and predictive values of p16 immunohistochemistry testing	14
Wolfram syndrome 1b mutation suppresses Mauthner-cell axon regeneration via ER stress signal pathway	13
EZHIP boosts neuronal-like synaptic gene programs and depresses polyamine metabolism	13
High-resolution transcriptomics informs glial pathology in human temporal lobe epilepsy	13
LATE-NC aggravates GVD-mediated necroptosis in Alzheimer’s disease	13
Laser microdissection-based multi-omics integration unveils the pathological atlas and tumor differentiation network of adamantinomatous craniopharyngioma	13
Correction to: Advanced immunotherapies for glioblastoma: tumor neoantigen vaccines in combination with immunomodulators	13
CNS embryonal tumour with concomitant novel BRD4::CTRC1 fusion and BCOR internal tandem duplication – evidence for synergism and non-mutually exclusive alterations in CNS embryonal tumours	13
Pituitary blastoma in a dog: comparative clinical, imaging, and pathologic features of a newly recognized and rare human entity	13
Beyond the brain: early autonomic dysfunction in Alzheimer’s disease	13
Disruption of mitochondrial homeostasis and permeability transition pore opening in OPA1 iPSC-derived retinal ganglion cells	13
Correction: Biglycan-driven risk stratification in ZFTA-RELA fusion supratentorial ependymomas through transcriptome profiling	13
Presymptomatic pharmacological inhibition of mGluR5 improves survival in a mouse model of prion diseases	13
NOP56 is essential for mammalian generation and maintenance of multiple central nervous systems, associated with SCA36 pathology	13
Expression of LTR and LINE1 transposable elements defines atypical teratoid/rhabdoid tumor subtypes	13
Correction to: Dynamic profiling of medulloblastoma surfaceome	13
Publisher Correction to: Diffuse argyrophilic grain disease with TDP-43 proteinopathy and neuronal intermediate filament inclusion disease: FTLD with mixed tau, TDP-43 and FUS pathologies	13
Alcohol-induced damage to the fimbria/fornix reduces hippocampal-prefrontal cortex connection during early abstinence	13
On the origin and development of glioblastoma: multifaceted role of perivascular mesenchymal stromal cells	13
Traumatic brain injury induces TDP-43 mislocalization and neurodegenerative effects in tissue distal to the primary injury site in a non-transgenic mouse	13
Correction: Clinical implications of DNA methylation-based integrated classification of histologically defined grade 2 meningiomas	13
Combination therapy of adagrasib and abemaciclib in non-small cell lung cancer brain metastasis models genomically characterized by KRAS-G12C and homozygous loss of CDKN2A	13
Correction: The formation of tau pore-like structures is prevalent and cell specific: possible implications for the disease phenotypes	13
Amygdala granular fuzzy astrocytes are independently associated with both LATE neuropathologic change and argyrophilic grains: a study of Japanese series with a low to moderate Braak stage	13
The enhanced association between mutant CHMP2B and spastin is a novel pathological link between frontotemporal dementia and hereditary spastic paraplegias	13
Cerebrovascular p16INK4A expression induces cerebral small vessel disease-related phenotypes	13
Stabilizing the retromer complex rescues synaptic dysfunction and endosomal trafficking deficits in an Alzheimer’s disease mouse model	13
Hippocampal capillary pericytes in post-stroke and vascular dementias and Alzheimer’s disease and experimental chronic cerebral hypoperfusion	13